China Universal Asset Management »

BioCryst Pharmaceuticals shares owned by China Universal Asset Management

Quarter-by-quarter ownership of BioCryst Pharmaceuticals (BCRX) shares owned by China Universal Asset Management from 13F filings

Historical chart of China Universal Asset Management investment in BioCryst Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including BioCryst Pharmaceuticals held by China Universal Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in BioCryst Pharmaceuticals by China Universal Asset Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $201k 40k 5.08
2023-12-31 $142k 24k 5.99
2023-09-30 $34k 4.9k 7.08
2023-06-30 $17k 2.5k 7.04
2023-03-31 $21k 2.6k 8.34
2022-12-31 $22k 1.9k 11.48
2022-09-30 $22k 1.7k 12.64

More positions owned by China Universal Asset Management

Microsoft Corp Common Stock (MSFT)
Nvidia Corp Common Stock (NVDA)
Amazon.com Common Stock (AMZN)
Meta Platforms Inc-class A Common Stock (META)
Vertex Pharmaceuticals Common Stock (VRTX)
Amgen Common Stock (AMGN)
Servicenow Common Stock (NOW)
Gilead Sciences Common Stock (GILD)
Regeneron Pharmaceuticals Common Stock (REGN)
Alphabet Inc-cl A Common Stock (GOOGL)
Adobe Common Stock (ADBE)
Broadcom Common Stock (AVGO)
Visa Inc-class A Shares Common Stock (V)
Apple Common Stock (AAPL)
Uber Technologies Common Stock (UBER)

View all positions for China Universal Asset Management

Top funds holding BioCryst Pharmaceuticals

BlackRock
Vanguard Group
venBio Select Advisor
Baker Bros. Advisors
Kynam Capital Management
Deerfield Management Company
Geode Capital Management
RP Management
Rock Springs Capital Management
Jennifer Ranahan
Braidwell
Fisher Investments
Nuveen Asset Management
Two Sigma Advisers
Ameriprise Financial

View all funds holding BioCryst Pharmaceuticals